Annual EBIT
-$23.77 M
+$824.00 K+3.35%
December 31, 2023
Summary
- As of February 7, 2025, MTNB annual earnings before interest & taxes is -$23.77 million, with the most recent change of +$824.00 thousand (+3.35%) on December 31, 2023.
- During the last 3 years, MTNB annual EBIT has risen by +$440.60 thousand (+1.82%).
- MTNB annual EBIT is now -540.18% below its all-time high of -$3.71 million, reached on December 31, 2013.
Performance
MTNB EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$4.38 M
+$1.46 M+24.97%
September 30, 2024
Summary
- As of February 7, 2025, MTNB quarterly earnings before interest & taxes is -$4.38 million, with the most recent change of +$1.46 million (+24.97%) on September 30, 2024.
- Over the past year, MTNB quarterly EBIT has increased by +$1.75 million (+28.58%).
- MTNB quarterly EBIT is now -3808.12% below its all-time high of -$112.10 thousand, reached on March 31, 2013.
Performance
MTNB Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$22.01 M
+$1.75 M+7.38%
September 30, 2024
Summary
- As of February 7, 2025, MTNB TTM earnings before interest & taxes is -$22.01 million, with the most recent change of +$1.75 million (+7.38%) on September 30, 2024.
- Over the past year, MTNB TTM EBIT has increased by +$1.35 million (+5.78%).
- MTNB TTM EBIT is now -19533.36% below its all-time high of -$112.10 thousand, reached on March 31, 2013.
Performance
MTNB TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
MTNB EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.4% | +28.6% | +5.8% |
| 3 y3 years | +1.8% | +28.6% | +5.8% |
| 5 y5 years | -62.3% | +28.6% | +5.8% |
MTNB EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +3.9% | at high | +43.3% | at high | +19.2% |
| 5 y | 5-year | -25.6% | +3.9% | at high | +43.3% | -16.3% | +19.2% |
| alltime | all time | -540.2% | +3.9% | -3808.1% | +43.3% | <-9999.0% | +19.2% |
Matinas BioPharma Holdings EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.38 M(-25.0%) | -$22.01 M(-7.4%) |
| Jun 2024 | - | -$5.84 M(-1.1%) | -$23.76 M(-1.3%) |
| Mar 2024 | - | -$5.90 M(+0.3%) | -$24.08 M(+1.3%) |
| Dec 2023 | -$23.77 M(-3.4%) | -$5.89 M(-4.0%) | -$23.77 M(+1.7%) |
| Sep 2023 | - | -$6.13 M(-0.4%) | -$23.36 M(+3.0%) |
| Jun 2023 | - | -$6.16 M(+10.3%) | -$22.69 M(+1.0%) |
| Mar 2023 | - | -$5.59 M(+1.9%) | -$22.45 M(-8.7%) |
| Dec 2022 | -$24.59 M(-0.6%) | -$5.48 M(+0.3%) | -$24.59 M(-4.8%) |
| Sep 2022 | - | -$5.46 M(-7.8%) | -$25.82 M(-5.2%) |
| Jun 2022 | - | -$5.92 M(-23.3%) | -$27.24 M(+4.3%) |
| Mar 2022 | - | -$7.72 M(+15.0%) | -$26.10 M(+5.5%) |
| Dec 2021 | -$24.73 M(+2.2%) | -$6.71 M(-2.4%) | -$24.73 M(+0.9%) |
| Sep 2021 | - | -$6.88 M(+43.6%) | -$24.51 M(+5.5%) |
| Jun 2021 | - | -$4.79 M(-24.6%) | -$23.24 M(-4.0%) |
| Mar 2021 | - | -$6.35 M(-2.1%) | -$24.21 M(+0.0%) |
| Dec 2020 | -$24.21 M(+27.9%) | -$6.49 M(+15.8%) | -$24.21 M(+3.2%) |
| Sep 2020 | - | -$5.60 M(-2.8%) | -$23.45 M(+4.7%) |
| Jun 2020 | - | -$5.77 M(-9.1%) | -$22.41 M(+5.9%) |
| Mar 2020 | - | -$6.35 M(+10.6%) | -$21.16 M(+11.9%) |
| Dec 2019 | -$18.92 M(+29.2%) | -$5.74 M(+25.8%) | -$18.92 M(+9.0%) |
| Sep 2019 | - | -$4.56 M(+0.9%) | -$17.35 M(+10.2%) |
| Jun 2019 | - | -$4.52 M(+10.2%) | -$15.74 M(+7.6%) |
| Mar 2019 | - | -$4.10 M(-1.5%) | -$14.63 M(-0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$14.65 M(-11.2%) | -$4.17 M(+41.0%) | -$14.65 M(-3.1%) |
| Sep 2018 | - | -$2.95 M(-13.2%) | -$15.11 M(-2.9%) |
| Jun 2018 | - | -$3.40 M(-17.4%) | -$15.56 M(-3.5%) |
| Mar 2018 | - | -$4.12 M(-11.0%) | -$16.14 M(-2.2%) |
| Dec 2017 | -$16.50 M(+99.9%) | -$4.63 M(+35.9%) | -$16.50 M(+14.3%) |
| Sep 2017 | - | -$3.41 M(-14.3%) | -$14.44 M(+12.2%) |
| Jun 2017 | - | -$3.98 M(-11.4%) | -$12.86 M(+22.4%) |
| Mar 2017 | - | -$4.49 M(+75.0%) | -$10.51 M(+27.2%) |
| Dec 2016 | -$8.26 M(-16.7%) | -$2.56 M(+39.7%) | -$8.26 M(-2.6%) |
| Sep 2016 | - | -$1.84 M(+13.3%) | -$8.48 M(-3.7%) |
| Jun 2016 | - | -$1.62 M(-27.6%) | -$8.80 M(-8.2%) |
| Mar 2016 | - | -$2.24 M(-19.6%) | -$9.58 M(-3.3%) |
| Dec 2015 | -$9.91 M(-5.3%) | -$2.78 M(+28.9%) | -$9.91 M(-5.1%) |
| Sep 2015 | - | -$2.16 M(-10.1%) | -$10.44 M(-4.1%) |
| Jun 2015 | - | -$2.40 M(-6.5%) | -$10.89 M(-0.2%) |
| Mar 2015 | - | -$2.57 M(-22.4%) | -$10.90 M(+4.2%) |
| Dec 2014 | -$10.46 M(+181.9%) | -$3.31 M(+27.1%) | -$10.46 M(+16.8%) |
| Sep 2014 | - | -$2.61 M(+7.6%) | -$8.96 M(+14.8%) |
| Jun 2014 | - | -$2.42 M(+13.7%) | -$7.81 M(+36.3%) |
| Mar 2014 | - | -$2.13 M(+18.0%) | -$5.73 M(+54.3%) |
| Dec 2013 | -$3.71 M | -$1.80 M(+24.1%) | -$3.71 M(+94.5%) |
| Sep 2013 | - | -$1.45 M(+323.2%) | -$1.91 M(+319.0%) |
| Jun 2013 | - | -$343.40 K(+206.3%) | -$455.50 K(+306.3%) |
| Mar 2013 | - | -$112.10 K | -$112.10 K |
FAQ
- What is Matinas BioPharma Holdings annual earnings before interest & taxes?
- What is the all time high annual EBIT for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual EBIT year-on-year change?
- What is Matinas BioPharma Holdings quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly EBIT year-on-year change?
- What is Matinas BioPharma Holdings TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings TTM EBIT year-on-year change?
What is Matinas BioPharma Holdings annual earnings before interest & taxes?
The current annual EBIT of MTNB is -$23.77 M
What is the all time high annual EBIT for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual earnings before interest & taxes is -$3.71 M
What is Matinas BioPharma Holdings annual EBIT year-on-year change?
Over the past year, MTNB annual earnings before interest & taxes has changed by +$824.00 K (+3.35%)
What is Matinas BioPharma Holdings quarterly earnings before interest & taxes?
The current quarterly EBIT of MTNB is -$4.38 M
What is the all time high quarterly EBIT for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly earnings before interest & taxes is -$112.10 K
What is Matinas BioPharma Holdings quarterly EBIT year-on-year change?
Over the past year, MTNB quarterly earnings before interest & taxes has changed by +$1.75 M (+28.58%)
What is Matinas BioPharma Holdings TTM earnings before interest & taxes?
The current TTM EBIT of MTNB is -$22.01 M
What is the all time high TTM EBIT for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high TTM earnings before interest & taxes is -$112.10 K
What is Matinas BioPharma Holdings TTM EBIT year-on-year change?
Over the past year, MTNB TTM earnings before interest & taxes has changed by +$1.35 M (+5.78%)